title: And what about epidermal growth factor (EGF) as the bridge between survivin and cardiac remodelling?
authors.forename: Raffaella
authors.initials: R
authors.lastname: Mormile
authors.forename: Mario
authors.initials: M
authors.lastname: De Michele
authors.forename: Umberto
authors.initials: U
authors.lastname: Squarcia
authors.forename: Federico
authors.initials: F
authors.lastname: Quaini
mesh_terms: D003920:Diabetes Mellitus / Q000378:metabolism / Q000503:physiopathology; D004815:Epidermal Growth Factor / Q000502:physiology*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D051034:Inhibitor of Apoptosis Proteins / Q000502:physiology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism / Q000503:physiopathology; D000077022:Survivin; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D000077022:Survivin; D004815:Epidermal Growth Factor